168 related articles for article (PubMed ID: 29920623)
1. Synergistic Anti-proliferative Effects of Metformin and Silibinin Combination on T47D Breast Cancer Cells via hTERT and Cyclin D1 Inhibition.
Chatran M; Pilehvar-Soltanahmadi Y; Dadashpour M; Faramarzi L; Rasouli S; Jafari-Gharabaghlou D; Asbaghi N; Zarghami N
Drug Res (Stuttg); 2018 Dec; 68(12):710-716. PubMed ID: 29920623
[TBL] [Abstract][Full Text] [Related]
2. Synergistic Growth Inhibitory Effects of Chrysin and Metformin Combination on Breast Cancer Cells through hTERT and Cyclin D1 Suppression.
Rasouli S; Zarghami N
Asian Pac J Cancer Prev; 2018 Apr; 19(4):977-982. PubMed ID: 29693804
[TBL] [Abstract][Full Text] [Related]
3. Synergistic Anticancer Effects of Silibinin and Chrysin in T47D Breast Cancer Cells.
Javan Maasomi Z; Pilehvar Soltanahmadi Y; Dadashpour M; Alipour Sh; Abolhasani S; Zarghami N
Asian Pac J Cancer Prev; 2017 May; 18(5):1283-1287. PubMed ID: 28610415
[TBL] [Abstract][Full Text] [Related]
4. Nano-encapsulated metformin-curcumin in PLGA/PEG inhibits synergistically growth and hTERT gene expression in human breast cancer cells.
Farajzadeh R; Pilehvar-Soltanahmadi Y; Dadashpour M; Javidfar S; Lotfi-Attari J; Sadeghzadeh H; Shafiei-Irannejad V; Zarghami N
Artif Cells Nanomed Biotechnol; 2018 Aug; 46(5):917-925. PubMed ID: 28678551
[TBL] [Abstract][Full Text] [Related]
5. MPEG-PCL Nanomicelles Platform for Synergistic Metformin and Chrysin Delivery to Breast Cancer in Mice.
Luo D; Wang X; Zhong X; Chang J; He M; Wang H; Li Y; Zhao C; Luo Y; Ran L
Anticancer Agents Med Chem; 2022; 22(2):280-293. PubMed ID: 34165412
[TBL] [Abstract][Full Text] [Related]
6. The Effect of Dual Bioactive Compounds Artemisinin and Metformin Co-loaded in PLGA-PEG Nano-particles on Breast Cancer Cell lines: Potential Apoptotic and Anti-proliferative Action.
Hassani N; Jafari-Gharabaghlou D; Dadashpour M; Zarghami N
Appl Biochem Biotechnol; 2022 Oct; 194(10):4930-4945. PubMed ID: 35674922
[TBL] [Abstract][Full Text] [Related]
7. Anticancer Potential of Silibinin Loaded Polymeric Nanoparticles against Breast Cancer Cells: Insight into the Apoptotic Genes Targets.
Pourgholi A; Dadashpour M; Mousapour A; Firouzi Amandi A; Zarghami N
Asian Pac J Cancer Prev; 2021 Aug; 22(8):2587-2596. PubMed ID: 34452574
[TBL] [Abstract][Full Text] [Related]
8. Curcumin and silibinin inhibit telomerase expression in T47D human breast cancer cells.
Nasiri M; Zarghami N; Koshki KN; Mollazadeh M; Moghaddam MP; Yamchi MR; Esfahlan RJ; Barkhordari A; Alibakhshi A
Asian Pac J Cancer Prev; 2013; 14(6):3449-53. PubMed ID: 23886126
[TBL] [Abstract][Full Text] [Related]
9. Metformin promotes apoptosis in primary breast cancer cells by downregulation of cyclin D1 and upregulation of P53 through an AMPK-alpha independent mechanism.
Yenmiş G; Beşli N; Yaprak Saraç E; Hocaoğlu Emre FS; Şenol K; Kanıgür G
Turk J Med Sci; 2021 Apr; 51(2):826-834. PubMed ID: 33350292
[TBL] [Abstract][Full Text] [Related]
10. A combination of the telomerase inhibitor, BIBR1532, and paclitaxel synergistically inhibit cell proliferation in breast cancer cell lines.
Shi Y; Sun L; Chen G; Zheng D; Li L; Wei W
Target Oncol; 2015 Dec; 10(4):565-73. PubMed ID: 25916999
[TBL] [Abstract][Full Text] [Related]
11. Metformin Modulates Cyclin D1 and P53 Expression to Inhibit Cell Proliferation and to Induce Apoptosis in Cervical Cancer Cell Lines.
Yudhani RD; Astuti I; Mustofa M; Indarto D; Muthmainah M
Asian Pac J Cancer Prev; 2019 Jun; 20(6):1667-1673. PubMed ID: 31244286
[TBL] [Abstract][Full Text] [Related]
12. Combination of metformin and phenformin synergistically inhibits proliferation and hTERT expression in human breast cancer cells.
Jafari-Gharabaghlou D; Pilehvar-Soltanahmadi Y; Dadashpour M; Mota A; Vafajouy-Jamshidi S; Faramarzi L; Rasouli S; Zarghami N
Iran J Basic Med Sci; 2018 Nov; 21(11):1167-1173. PubMed ID: 30483391
[TBL] [Abstract][Full Text] [Related]
13. Development of a Magnetic Nanostructure for Co-delivery of Metformin and Silibinin on Growth of Lung Cancer Cells: Possible Action Through Leptin Gene and its Receptor Regulation.
Salmani Javan E; Lotfi F; Jafari-Gharabaghlou D; Mousazadeh H; Dadashpour M; Zarghami N
Asian Pac J Cancer Prev; 2022 Feb; 23(2):519-527. PubMed ID: 35225464
[TBL] [Abstract][Full Text] [Related]
14. Aloe vera inhibits proliferation of human breast and cervical cancer cells and acts synergistically with cisplatin.
Hussain A; Sharma C; Khan S; Shah K; Haque S
Asian Pac J Cancer Prev; 2015; 16(7):2939-46. PubMed ID: 25854386
[TBL] [Abstract][Full Text] [Related]
15. Metformin and the mTOR inhibitor everolimus (RAD001) sensitize breast cancer cells to the cytotoxic effect of chemotherapeutic drugs in vitro.
Liu H; Scholz C; Zang C; Schefe JH; Habbel P; Regierer AC; Schulz CO; Possinger K; Eucker J
Anticancer Res; 2012 May; 32(5):1627-37. PubMed ID: 22593441
[TBL] [Abstract][Full Text] [Related]
16. Metformin inhibits human breast cancer cell growth by promoting apoptosis via a ROS-independent pathway involving mitochondrial dysfunction: pivotal role of superoxide dismutase (SOD).
Sharma P; Kumar S
Cell Oncol (Dordr); 2018 Dec; 41(6):637-650. PubMed ID: 30088260
[TBL] [Abstract][Full Text] [Related]
17. Arsenic trioxide and BIBR1532 synergistically inhibit breast cancer cell proliferation through attenuation of NF-κB signaling pathway.
Nasrollahzadeh A; Bashash D; Kabuli M; Zandi Z; Kashani B; Zaghal A; Mousavi SA; Ghaffari SH
Life Sci; 2020 Sep; 257():118060. PubMed ID: 32645343
[TBL] [Abstract][Full Text] [Related]
18. Mucuna pruriens (L.) DC chemo sensitize human breast cancer cells via downregulation of prolactin-mediated JAK2/STAT5A signaling.
Sinha S; Sharma S; Vora J; Shah H; Srivastava A; Shrivastava N
J Ethnopharmacol; 2018 May; 217():23-35. PubMed ID: 29427634
[TBL] [Abstract][Full Text] [Related]
19. Co-treatment of breast cancer cells with pharmacologic doses of 2-deoxy-D-glucose and metformin: Starving tumors.
Wokoun U; Hellriegel M; Emons G; Gründker C
Oncol Rep; 2017 Apr; 37(4):2418-2424. PubMed ID: 28350075
[TBL] [Abstract][Full Text] [Related]
20. siRNA inhibition of telomerase enhances the anti-cancer effect of doxorubicin in breast cancer cells.
Dong X; Liu A; Zer C; Feng J; Zhen Z; Yang M; Zhong L
BMC Cancer; 2009 May; 9():133. PubMed ID: 19416503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
